课题基金 / 基金详情

项目摘要

项目成果

BRADLEY K HAYES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The purpose of the Analytical Glycotechnology Core is to provide the technical expertise and instrumentation necessary to structurally characterize sialic acids,N- and O-linked oligosaccharides or glycosaminoglycans isolated from either proteins, cells or tissues from transgenic animals provided by the Project Leaders' laboratories. The Core will greatly benefit from access to the instruments, reagents and expertise in the existing Glycotechnology Resource Core of the UCSD Glycobiology Research and Training Center (GRTC). Many of the techniques to be employed for these analyses (lipid extraction, isolation of glycans, monosaccharide analysis, methylation linkage analysis, glycosaminoglycan disaccharide analysis) were devised or implemented during the previous funding period. Others have only recently become available as the GRTC Core has added new, state-of-the-art equipment geared toward improving sensitivity. These upgrades include a nanospray source for the existing LC-Q mass spectrometer, a MALDI-TOF mass spectrometry, a high sensitivity fluorescence detector, and a new nanoprobe for the NMR. The availability of high quality instrumentation, coupled with the many combined years of analytical glycobiology experience represented by the members of the GRTC Glycotechnology Resource, allow us to meet the analytical challenges posed the Project Leaders and perform the analyses necessary to support their research aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ABI QSTAR XL Q-Q TOF Mass Spectrometer
ABI QSTAR XL Q-Q TOF MASS SPECTROMETER: VASCULAR BIOLOGY
ABI QSTAR XL Q-Q TOF MASS SPECTROMETER: GROUP A & B STREPTOCOCCUS (GAS DISEASES)
ABI QSTAR XL Q-Q TOF MASS SPECTROMETER: DIABETES
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: